This HTML5 document contains 213 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1056/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q30371806
rdf:type
wikibase:Item
schema:description
บทความทางวิทยาศาสตร์ wetenschappelijk artikel mokslinis straipsnis научни чланак naučni članak article scientifique (publié 2013) مقالة علمية (نشرت في 19-6-2013) articolo scientifico 2013年論文 мақолаи илмӣ vedecký článok articol științific επιστημονικό άρθρο 2013年論文 scientific article article scientific artigo científico (publicado na 2013) artikulong pang-agham tudományos cikk artykuł naukowy 2013年论文 2013年の論文 научна статия مقالهٔ علمی наукова стаття, опублікована в червні 2013 artículo científico publicado en 2013 2013年論文 bài báo khoa học 2013年论文 videnskabelig artikel (udgivet 2013) мақолаи илмӣ wissenschaftlicher Artikel bilimsel makale научни чланак ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי artículu científicu espublizáu en 2013 2013년 논문 სამეცნიერო სტატია 2013 nî lūn-bûn artigo científico tieteellinen artikkeli scienca artikolo vetenskaplig artikel teaduslik artikkel artigo científico (publicado na 2013) artikull shkencor 2013 թվականի հունիսին հրատարակված գիտական հոդված 2013年论文 2013 թուականի Յունիսին հրատարակուած գիտական յօդուած سائنسی مضمون vitenskapelig artikkel vědecký článek 2013年論文 2013年论文 2013年论文 научная статья vitskapeleg artikkel article científic 2013年論文 2013年论文
p:P577
wds:Q30371806-B509E650-4A59-4FC9-9163-246FDD62C918
wdt:P577
2013-06-19T00:00:00Z
p:P407
wds:Q30371806-9AB0D028-6840-4C52-BDF9-81EB31AE9EB3
wdt:P407
wd:Q1860
p:P2860
wds:Q30371806-70590171-5462-46D9-A04F-5D6FF8317AF8 wds:Q30371806-7612A3BF-AF6A-4C76-8925-399CBB22A690 wds:Q30371806-8FFAE385-3E44-479D-AB90-3FDA177F8D90 wds:Q30371806-918476D2-0093-4CA8-8040-6B37EAEDF993 wds:Q30371806-2A7475F1-713D-4790-98B7-448912D6E4BC wds:Q30371806-30982C2F-A9CB-4AE8-9470-DB2DA252A4E7 wds:Q30371806-4AA06115-4E0F-48EE-943D-673645C0D6D2 wds:Q30371806-524215A2-82BB-4A1D-B4FE-3255459C8651 wds:Q30371806-529A860D-D937-4CF6-AA24-EA3F08CE4F3A wds:Q30371806-59794532-D7AD-4CEF-8019-7B208072C869 wds:Q30371806-5A8DD063-4F24-4D63-A4E2-E598D4B484C1 wds:Q30371806-D225E3F7-D2D1-4308-B317-56B740C749A9 wds:Q30371806-D2C99CBA-151B-4A2E-B1A9-4139AE8E4D4B wds:Q30371806-D41CD3D9-A732-4B5E-BED9-709869FD4F9D wds:Q30371806-D61C4932-25FA-4BE2-A54E-F0F3BDEBF436 wds:Q30371806-DF0B839C-0B77-449B-ADF3-35276FDF905F wds:Q30371806-EB2303F4-537B-48CB-8036-79ACFF6A07FC wds:Q30371806-EDBA1604-BAE8-41B4-83E8-33A77BA2D2FD wds:Q30371806-FA9E0748-EDB1-455F-8863-5229FB21DE09 wds:Q30371806-FF332175-E619-462A-91AC-89F2AAA9DDBB wds:Q30371806-A47E9407-A987-4292-AD88-A4DCEB136DDE wds:Q30371806-A69425B2-1E91-4E4C-830B-DF56E81150ED wds:Q30371806-A8FCF512-9E4E-49B5-BD11-A4EADCB18559 wds:Q30371806-AD7C02A0-0FC2-47B0-BEB8-052C087D82E7 wds:Q30371806-101C1FC3-4A63-40B9-9A05-DAA319DA5EBC wds:Q30371806-216CCA8C-5920-4F8F-9414-389005D3514A
wdt:P2860
wd:Q34249777 wd:Q40330626 wd:Q46669623 wd:Q44542640 wd:Q72504210 wd:Q54535155 wd:Q37997075 wd:Q34037828 wd:Q54478992 wd:Q33372761 wd:Q33385283 wd:Q35889841 wd:Q37763259 wd:Q42610807 wd:Q38057907 wd:Q47582438 wd:Q29620690 wd:Q44433269 wd:Q24613755 wd:Q38017940 wd:Q33381844 wd:Q46412217 wd:Q33893704 wd:Q28239256 wd:Q43738375 wd:Q34026194
p:P2093
wds:Q30371806-ABD15686-CBB5-43C2-AA96-6D4591064503 wds:Q30371806-A83FB0AF-8C96-4348-875F-58EAEBC8D402 wds:Q30371806-A83EAB17-698B-4E21-BEE3-902BE26B8D82 wds:Q30371806-CD1591B7-9A0A-418B-972D-2791604F5F08 wds:Q30371806-CF7F46FE-0284-4E42-A174-9686D535ECBC wds:Q30371806-4774DC31-A516-47F2-9741-E477C41811F6 wds:Q30371806-38DDCB55-C022-49F1-A365-C580A1314264 wds:Q30371806-2B4C6132-48F0-48F0-AA83-1F68D654EC0C wds:Q30371806-5FA98562-9656-4701-B3D7-BF27C1095D3A wds:Q30371806-67DFD745-D169-42E6-8F6B-78062A5DC852 wds:Q30371806-25C945BC-723B-44A5-88EF-69BA576490BA wds:Q30371806-15D6D4D6-D1B6-4E0F-9B0A-807C57CA1BC9
wdt:P2093
Lei Li Peter Martin Betty Y Chang Kate Newberry Bingliang Fang Joseph J Buggy Zhishuo Ou Michael L Wang Michael E Williams Liang Zhang Lori A Kunkel Nancy Cheng
rdfs:label
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
skos:prefLabel
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
schema:name
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
p:P50
wds:Q30371806-3924229C-8CAD-42D7-B5CE-E316DE4A4B50 wds:Q30371806-30B1977E-F942-4222-8664-B515D770906F wds:Q30371806-89CF65D6-63AC-4175-8DE8-F88A6C09C5A4 wds:Q30371806-947E6BB4-E748-42EC-AE4C-C58F8491E8A9 wds:Q30371806-7F980DD4-F6BC-427F-8BB0-A8C7D628218C wds:Q30371806-8815920C-3942-4312-A7E0-29282FECD765 wds:Q30371806-6D539199-DB55-4D40-AE1F-F07172C93984 wds:Q30371806-60B91D4C-5FE3-4E17-B66E-6B8327984F99 wds:Q30371806-6643BD19-1ED3-4CF6-8789-E5E931F40561 wds:Q30371806-67B0E228-7D68-48CB-9FB9-C56292761FEB wds:Q30371806-C7A4E39F-5945-4C40-901D-99B7813F9834 wds:Q30371806-C3332FC7-26C7-4690-BCD7-2EDD1333B407 wds:Q30371806-A8B00B62-9B04-4CEE-B198-8A02CC37366A wds:Q30371806-EC08B861-C660-4AF5-800A-CF3E94A8D485 wds:Q30371806-1D43D414-96ED-4649-A757-51B464CEBC23 wds:Q30371806-1F89CA87-662C-4819-BAC7-2E5256F4D77F wds:Q30371806-1643DE54-259D-4EC7-9DBA-4D6184BE93BC wds:Q30371806-013D3205-8AF6-45FF-8E74-A968893FB6EC wds:Q30371806-0993508C-0F9D-42C1-936E-02B07A36270B
wdt:P50
wd:Q42165364 wd:Q62592210 wd:Q42388605 wd:Q87753381 wd:Q88392222 wd:Q42815591 wd:Q90691651 wd:Q92610349 wd:Q124727575 wd:Q114341060 wd:Q114341062 wd:Q47158807 wd:Q9373502 wd:Q102148850 wd:Q88022461 wd:Q57724597 wd:Q114290912 wd:Q95603491 wd:Q23062092
p:P1476
wds:Q30371806-506A2C99-805F-4217-B6F5-45DBB9C5E59D
wdt:P1476
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
p:P304
wds:Q30371806-8574AD18-354C-4BA5-8D92-9E0B1C27362C
wdt:P304
507-516
p:P31
wds:Q30371806-1AC0405F-C4A9-4908-AEB7-8B114E6463F6
wdt:P31
wd:Q13442814
p:P921
wds:Q30371806-82ECB37D-49E9-4982-AFE6-BA4E440C83D2
wdt:P921
wd:Q5984881
p:P698
wds:Q30371806-66B1C1B5-08FC-448A-81F0-0E907AF4C502
wdtn:P698
n10:23782157
wdt:P698
23782157
p:P1433
wds:Q30371806-F730C6FB-F168-4C21-AC16-949948EB18F2
wdt:P1433
wd:Q582728
p:P433
wds:Q30371806-06AC08C1-92EC-4FA5-A28E-7BD402E8708F
p:P478
wds:Q30371806-45F6D06A-80D8-4FE4-AF76-EB290C38F763
wdt:P433
6
wdt:P478
369
p:P356
wds:Q30371806-C5C7F84E-B694-4AF5-815F-B2AAD1517F7D
wdtn:P356
n11:NEJMOA1306220
wdt:P356
10.1056/NEJMOA1306220
p:P5875
wds:Q30371806-57EFABE1-9E2F-4D82-BC5F-8C5D16945AF1
wdt:P5875
239940905
p:P932
wds:Q30371806-C768324F-84BC-463C-AE05-4AE0AA5399F5
wdt:P932
4513941